ZYXI Conference call. https://seekingalpha.com/article/4194902-zynex-inc-zyxi-ceo-thomas-sandgaard-q2-2018-results-earnings-call-transcript Very bullish. Hiring a bunch of new salespeople. Market size is 8x their current revenue with only small regional competitors. 82% margins. 80% recurring revenue. 9x PE. Bought back $2 million in shares and still added cash to the balance sheet which has no debt. 50% year over year growth. Plus if their blood monitoring device gets approved that market is 8x the size of their current market with better margins. Insider buying. Potential Nasdaq uplist.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.